BAUDAX BIO INC's ticker is BXRX and the CUSIP is 07160F107. A total of 49 filers reported holding BAUDAX BIO INC in Q2 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $927,000 | – | 373,977 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CVI Holdings, LLC | 432,325 | $1,072,000 | 3.76% |
NORTH RUN CAPITAL, LP | 1,152,539 | $2,858,000 | 2.87% |
Stonepine Capital Management, LLC | 610,200 | $1,513,000 | 1.60% |
Corsair Capital Management | 880,310 | $2,183,000 | 1.04% |
SABBY MANAGEMENT, LLC | 373,977 | $927,000 | 0.38% |
Engine Capital Management, LP | 78,787 | $545,000 | 0.28% |
OBERWEIS ASSET MANAGEMENT INC/ | 91,620 | $227,000 | 0.12% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 98,385 | $244,000 | 0.05% |
Alyeska Investment Group, L.P. | 815,384 | $2,022,000 | 0.04% |
Ikarian Capital, LLC | 175,000 | $434,000 | 0.03% |